Tehami Dermatology

    Isotretinoin prescribing and monitoring

    Dose, cumulative target, laboratory monitoring, pregnancy prevention and the counselling points that matter.

    Updated: 2026-09-12

    Written for clinicians and medical students

    This section is a teaching reference for doctors, residents and medical students. It is not patient guidance and not a substitute for clinical examination, and it must not be used for self treatment.

    Dosing

    • Usual range 0.3 to 1 mg per kg per day, taken with a fatty meal to improve absorption.
    • Starting low and building up reduces the early flare, particularly in severe nodular acne.
    • Cumulative dose of roughly 120 to 150 mg per kg is associated with lower relapse rates, although lower cumulative dosing is used in selected patients [1].

    Monitoring

    • Baseline: liver function, fasting lipids, and a pregnancy test in anyone who can become pregnant.
    • Repeat liver function and lipids after 4 to 8 weeks; further routine testing is reduced in stable patients on a stable dose.
    • Monthly pregnancy testing and reliable contraception from one month before to one month after treatment.
    • Ask at every visit about mood, since counselling and monitoring for depressive symptoms remain part of safe prescribing.

    Counselling

    • Dryness of lips, eyes and nose is universal. Provide lip balm and artificial tears from day one.
    • Avoid waxing, dermabrasion and elective resurfacing during treatment and for 6 months after.
    • No blood donation during treatment and for one month after.
    • Photosensitivity matters in the Iraqi climate: daily broad spectrum sunscreen and sun avoidance at midday.

    Sources

    1. [1] Isotretinoin dosing and relapse, PubMed
    2. [2] AAD acne guideline

    By continuing to use this website, you accept our collection of the information necessary to provide our services. See our Privacy Policy.